Abstract:Background and purpose This study was to investigate the association of H-type hypertension with the odds of incident stroke and stroke death in Chinese adults. Methods 39,165 Chinese adults aged 35 years or older who had no history of stroke at baseline were prospectively followed to determine major cardiovascular events, with an average follow-up of 6.2 years. Using a nested case–control design, this report included 179 incident stroke cases (121 stroke deaths) and 179 controls without vascular events matched by age, sex, community, and length of plasma storage from the cohort. Baseline plasma total homocysteine (tHcy) level was measured for all the included subjects. Hypertensive patients, co-morbid with elevated plasma homocysteine levels, are defined as H-type hypertension. Logistic regression analysis was performed to investigate the associations of H-type hypertension with the odds of incident stroke and stroke death, with adjustment for important covariates. Results When analyzed individually, compared to subjects with tHcy<10 μmol/L, the OR (95% CI) of incident stroke for those with tHcy≥10 μmol/L but <20 μmol/L and tHcy≥20 μmol/L were 1.7 (0.8–3.7) and 2.9 (1.1–8.0), respectively. Hypertension was also independently associated with higher risk of incident stroke: 4.7 (2.8–7.9), compared to those without hypertension. When analyzed together, the highest risk was found among subjects with both hyperhomocysteinemia and hypertension (H-type hypertension): 13.5 (3.0–61.5) for incident stroke and 12.4 (2.7 to 58.1) for stroke death. Conclusion This study provided strong evidence that hyperhomocysteinemia and hypertension were two independent, modifiable risk factors, which acted at least additively to increase the risk of incident stroke and stroke death in Chinese population. Background and purpose This study was to investigate the association of H-type hypertension with the odds of incident stroke and stroke death in Chinese adults. Methods 39,165 Chinese adults aged 35 years or older who had no history of stroke at baseline were prospectively followed to determine major cardiovascular events, with an average follow-up of 6.2 years. Using a nested case–control design, this report included 179 incident stroke cases (121 stroke deaths) and 179 controls without vascular events matched by age, sex, community, and length of plasma storage from the cohort. Baseline plasma total homocysteine (tHcy) level was measured for all the included subjects. Hypertensive patients, co-morbid with elevated plasma homocysteine levels, are defined as H-type hypertension. Logistic regression analysis was performed to investigate the associations of H-type hypertension with the odds of incident stroke and stroke death, with adjustment for important covariates. Results When analyzed individually, compared to subjects with tHcy<10 μmol/L, the OR (95% CI) of incident stroke for those with tHcy≥10 μmol/L but <20 μmol/L and tHcy≥20 μmol/L were 1.7 (0.8–3.7) and 2.9 (1.1–8.0), respectively. Hypertension was also independently associated with higher risk of incident stroke: 4.7 (2.8–7.9), compared to those without hypertension. When analyzed together, the highest risk was found among subjects with both hyperhomocysteinemia and hypertension (H-type hypertension): 13.5 (3.0–61.5) for incident stroke and 12.4 (2.7 to 58.1) for stroke death. Conclusion This study provided strong evidence that hyperhomocysteinemia and hypertension were two independent, modifiable risk factors, which acted at least additively to increase the risk of incident stroke and stroke death in Chinese population.

Impact of hyperhomocysteinemia on insulin resistance in patients with H-type hypertension

Coronary flow velocity reserve is impaired in hypertensive patients with hyperhomocysteinemia

[Relationship Between Plasma Total Homocysteine and Mild Cognitive Impairment in Senile Patients with Type 2 Diabetes].

Novel Clinical Evidence of an Association between Homocysteine and Insulin Resistance in Patients with Hypothyroidism or Subclinical Hypothyroidism

Association of High Homocysteine Levels With the Risk Stratification in Hypertensive Patients at Risk of Stroke

Homocysteine, hyperhomocysteinemia, and H-type hypertension

Relationship between Plasma Phospholipid Fatty Acid Profile and Insulin Resistance in Type 2 Diabetics

Hyperhomocysteinemia Promotes Insulin Resistance by Inducing Endoplasmic Reticulum Stress in Adipose Tissue

H-type Hypertension and Risk of Stroke in Chinese Adults: A Prospective, Nested Case–control Study

Elevated Total Plasma Homocysteine Levels Are Associated with Type 2 Diabetes in Women with Hypertension.

The correlation between blood pressure and homocysteine in Chinese type Ⅱ diabetes

The Association Between Total Homocysteine and Blood Pressure in Two Independent Chinese Populations.

Prevalence and clinical correlates of hyperhomocysteinemia in Chinese urban population with hypertension

Plasma Phospholipid Polyunsaturated Fatty Acids and Homocysteine in Chinese Type 2 Diabetes Patients

Homocysteine,blood lipid,renal function and carotid ultrasound in H-type hypertension

H-type Hypertension and Risk of Stroke: A Prospective, Nested Case–control Study

Association between homocysteine and incidence of ischemic stroke in subjects with essential hypertension: a matched case-control study.

Prevalence of Hyperhomocysteinemia (hhcy) and Its Major Determinants among Hypertensive Patients over 35 Years of Age.

Dapagliflozin's effect on serum homocysteine in patients with hypertension complicated with insulin resistance

Hypertension with Elevated Homocysteine——H Type Hypertension

Hcy levels in insulin resistance and diabetes